The author of the critically-acclaimed book on patient advocacy, When Doctors Don’t Listen: How to Avoid Misdiagnoses and Unnecessary Tests (St. Martin’s Press, 2013), she has a forthcoming memoir to be published July 27th, Lifelines: A Doctor’s Journey in the Fight for Public Health (Metropolitan Books, 2021).
Previously, she served as health commissioner for the city of Baltimore, where she led the nation’s oldest continuously operating health department to combat the opioid epidemic and improve maternal and child health. She has also worked as director of patient-centered care research in the department of emergency medicine at George Washington University; president of Planned Parenthood; global health fellow at the World Health Organization; consultant to the China Medical Board; and distinguished fellow at the Fitzhugh Mullan Institute for Health Workforce Equity.
Currently, Dr. Wen serves on the board of directors of Glaukos Corporation and as the chair of the advisory board of the Behavioral Health Group. She is also a member of the board of directors of the Bipartisan Policy Center and the Baltimore Community Foundation. Her previous board experience includes being board chair of Behavioral Health System Baltimore for four years and serving on boards and advisory of boards to more than ten nonprofit and venture-backed health innovation companies.
Dr. Wen obtained her medical degree from Washington University School of Medicine and studied health policy at the University of Oxford, where she was a Rhodes Scholar. She completed her residency training at Brigham & Women's Hospital & Massachusetts General Hospital, where she was a clinical fellow at Harvard Medical School.
A member of the Council on Foreign Relations, Dr. Wen has received recognition as one of Governing's Public Officials of the Year, Modern Healthcare's Top 50 Physician-Executives, World Economic Forum’s Young Global Leaders, and TIME magazine's 100 Most Influential People.
Dr. Wen lives with her husband and their two young children in Baltimore.